Hualan Biological Vaccine Inc
301207
Company Profile
Business description
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.
Contact
No. 1, No. 1, Hualan Avenue
Henan Province
Xinxiang453003
CHNT: +86 3733559909
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
748
Stocks News & Analysis
stocks
After Earnings, is Alphabet stock a buy, a sell, or fairly valued?
With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
stocks
Moated ASX share crashes amid weak trading update
Bapcor signalled lower underlying profits for fiscal 2025, while an audit cast doubt on the firm’s past earnings.
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,025.40 | 58.70 | 0.65% |
| CAC 40 | 7,857.36 | 56.48 | 0.72% |
| DAX 40 | 24,217.37 | 247.01 | 1.03% |
| Dow JONES (US) | 44,632.99 | 204.57 | -0.46% |
| FTSE 100 | 9,136.32 | 54.88 | 0.60% |
| HKSE | 25,415.94 | 108.51 | -0.43% |
| NASDAQ | 21,098.29 | 80.29 | -0.38% |
| Nikkei 225 | 40,721.01 | 46.46 | 0.11% |
| NZX 50 Index | 12,937.02 | 0.61 | 0.00% |
| S&P 500 | 6,370.86 | 18.91 | -0.30% |
| S&P/ASX 200 | 8,766.50 | 61.90 | 0.71% |
| SSE Composite Index | 3,628.53 | 18.82 | 0.52% |